Development of Novel VEGFR2 Inhibitors Originating from Natural Product Analogues with Antiangiogenic Impact-Reference-Cited by-同舟云学术

Development of Novel VEGFR2 Inhibitors Originating from Natural Product Analogues with Antiangiogenic Impact

Published:2021-11-03 Issue:21 Volume:64 Page:15858-15867
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Cho Sung Min¹^ORCID,Kim Yonghyo¹²,Jung Yooju¹,Ko Minjeong¹,Marko-Varga Gyorgy¹²,Kwon Ho Jeong¹³^ORCID

Affiliation:

1. Chemical Genomics Global Research Laboratory, Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul 03722, Republic of Korea

2. Clinical Protein Science & Imaging, Biomedical Centre, Department of Biomedical Engineering, Lund University, BMC D13, 221 84 Lund, Sweden

3. Department of Internal Medicine, College of Medicine, Yonsei University, Seoul 03722, Republic of Korea

Funder

Fru Berta Kamprads Stiftelse

Medicinska Fakulteten, Lunds Universitet

The Anders and Birgit Andersson Research Foundation,

Brain Korea 21 Plus Project

National Research Foundation of Korea

Anders and Birgit Andersson Research Foundation

ICONS, Yonsei University

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.1c01168

Reference26 articles.

1. Angiogenesis in cancer, vascular, rheumatoid and other disease

2. Angiogenesis in cancer

3. Anti-Angiogenesis

4. Limitations of Anti-Angiogenic Treatment of Tumors

5. Angiogenesis inhibitors as therapeutic agents in cancer: Challenges and future directions

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of newer generation Vascular endothelial growth factor Receptor-2 Inhibitors: Pharmacophore based design, virtual Screening, molecular Docking, molecular dynamic Simulation, and DFT analyses;Journal of King Saud University - Science;2024-09

2. Natural Compound‐Rhein and PROTACs Unleash Potent VEGFR‐2 Degraders;Chemistry & Biodiversity;2024-07-17

3. Recent advances and future directions on small molecule VEGFR inhibitors in oncological conditions;European Journal of Medicinal Chemistry;2024-06

4. Voacangine protects hippocampal neuronal cells against oxygen–glucose deprivation/reoxygenation‐caused oxidative stress and ferroptosis by activating the PI3K‐Akt‐FoxO signaling;Journal of Applied Toxicology;2024-04-26

5. Small Molecule Tyrosine Kinase Inhibitors (TKIs) for Glioblastoma Treatment;International Journal of Molecular Sciences;2024-01-23